120 related articles for article (PubMed ID: 16351556)
21. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
22. Effects of an asthma management program on the asthmatic member: patient-centered results of a 2-year study in a managed care organization.
Buchner DA; Butt LT; De Stefano A; Edgren B; Suarez A; Evans RM
Am J Manag Care; 1998 Sep; 4(9):1288-97. PubMed ID: 10185979
[TBL] [Abstract][Full Text] [Related]
23. Applying the benefits of the AwM study in the clinic.
Dodick DW
Cephalalgia; 2008 Sep; 28 Suppl 2():42-9. PubMed ID: 18715332
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine.
Lofland JH; Kim SS; Batenhorst AS; Johnson NE; Chatterton ML; Cady RK; Kaniecki R; Nash DB
Mayo Clin Proc; 2001 Nov; 76(11):1093-101. PubMed ID: 11702897
[TBL] [Abstract][Full Text] [Related]
25. A cross-sectional survey to assess the migraineur's medication decision-making beliefs: determining when a migraine is triptan-worthy.
Landy SH; Turner IM; Runken MC; Lee M; Sulcs E; Bell CF
Headache; 2013; 53(7):1134-46. PubMed ID: 23773016
[TBL] [Abstract][Full Text] [Related]
26. Assessment and treatment of the burden of migraine: a case series.
Bryson J; Buse DC; Lipton RB
Neurologist; 2010 Jul; 16(4):254-61. PubMed ID: 20592569
[TBL] [Abstract][Full Text] [Related]
27. Acupuncture in migraine prevention: a randomized sham controlled study with 6-months posttreatment follow-up.
Alecrim-Andrade J; Maciel-Júnior JA; Carnè X; Severino Vasconcelos GM; Correa-Filho HR
Clin J Pain; 2008 Feb; 24(2):98-105. PubMed ID: 18209514
[TBL] [Abstract][Full Text] [Related]
28. The preliminary effectiveness of migraine lay trainers in a home-based behavioural management training.
Mérelle SY; Sorbi MJ; Passchier J
Patient Educ Couns; 2006 May; 61(2):307-11. PubMed ID: 15896944
[TBL] [Abstract][Full Text] [Related]
29. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
Vicente-Herrero T; Burke TA; Laínez MJ
Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
[TBL] [Abstract][Full Text] [Related]
30. Moving forward to improve migraine management in Canada.
Becker WJ; Giammarco R; Wiebe V
Can J Neurol Sci; 2007 Nov; 34(4):S20-6. PubMed ID: 18062467
[TBL] [Abstract][Full Text] [Related]
31. Medium-term effectiveness of online behavioral training in migraine self-management: A randomized trial controlled over 10 months.
Sorbi MJ; Kleiboer AM; van Silfhout HG; Vink G; Passchier J
Cephalalgia; 2015 Jun; 35(7):608-18. PubMed ID: 25228685
[TBL] [Abstract][Full Text] [Related]
32. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
Bigal ME; Serrano D; Reed M; Lipton RB
Neurology; 2008 Aug; 71(8):559-66. PubMed ID: 18711108
[TBL] [Abstract][Full Text] [Related]
33. Validation of a survey tool assessing effectiveness of an educational intervention on the caring behaviors and referral activities of community pharmacists for migraineurs.
O'Neal KS; Murray KA; Skomo ML; Carter SM; McConaha J
Res Social Adm Pharm; 2015; 11(3):352-63. PubMed ID: 25483402
[TBL] [Abstract][Full Text] [Related]
34. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences.
Cohen JA; Beall DG; Miller DW; Beck A; Pait G; Clements BD
Fam Med; 1996 Mar; 28(3):171-7. PubMed ID: 8900548
[TBL] [Abstract][Full Text] [Related]
35. An instrument to assess patient perceptions of satisfaction with acute migraine treatment (EXPERT Study).
Lantéri-Minet M; Massiou H; Romatet S; Barba A; Lucas C; Allaf B
Headache; 2011 Apr; 51(4):590-601. PubMed ID: 21457243
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of biofeedback in the treatment of migraine and tension type headaches.
Mullally WJ; Hall K; Goldstein R
Pain Physician; 2009; 12(6):1005-11. PubMed ID: 19935987
[TBL] [Abstract][Full Text] [Related]
37. Stop the pain! A nation-wide quality improvement programme in paediatric oncology pain control.
Zernikow B; Hasan C; Hechler T; Huebner B; Gordon D; Michel E
Eur J Pain; 2008 Oct; 12(7):819-33. PubMed ID: 18222100
[TBL] [Abstract][Full Text] [Related]
38. The impact of intensive patient education on clinical outcome in a clinic-based migraine population.
Rothrock JF; Parada VA; Sims C; Key K; Walters NS; Zweifler RM
Headache; 2006 May; 46(5):726-31. PubMed ID: 16643574
[TBL] [Abstract][Full Text] [Related]
39. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres.
Cevoli S; D'Amico D; Martelletti P; Valguarnera F; Del Bene E; De Simone R; Sarchielli P; Narbone M; Testa L; Genco S; Bussone G; Cortelli P
Cephalalgia; 2009 Dec; 29(12):1285-93. PubMed ID: 19438916
[TBL] [Abstract][Full Text] [Related]
40. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
